7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, GF; Linderkamp, O; Mayatepek, E; Meyburg, J; Seyberth, HW | 1 |
1 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Syndrome
| Article | Year |
|---|---|
Severe hyperchloriduria-hyperkaliuria: a new congenital renal tubular abnormality?
Topics: Bartter Syndrome; Calcium; Chlorides; Cyclooxygenase Inhibitors; Dinoprostone; Female; Humans; Indomethacin; Infant; Potassium; Prostaglandins; Renal Tubular Transport, Inborn Errors; Syndrome | 1996 |